Researchers at Osaka Metropolitan University in Japan have reported that the drug lecanemab, which targets amyloid plaques in Alzheimer’s patients, does not enhance the...
Concerns about the potential hereditary nature of cognitive decline have been addressed by Dr. Kellyn Lee, a psychologist and CEO of the Dementia Care...
A groundbreaking blood test trial for Alzheimer’s disease is currently underway in the United Kingdom, aiming to enhance the accuracy and timeliness of diagnosis...
A study has revealed that sodium benzoate, a common food preservative found in sodas and various processed foods, may enhance cognitive function in individuals...
Biogen Inc. CEO Chris Viehbacher expressed optimism that a successful trial of Novo Nordisk A/S’s weight-loss drug could pave the way for innovative treatments...